Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
about
IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansOropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 TransgeneMucosal candidiasis elicits NF-κB activation, proinflammatory gene expression and localized neutrophilia in zebrafishTh17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa.Free IL-12p40 monomer is a polyfunctional adaptor for generating novel IL-12-like heterodimers extracellularlyDifferent tumor necrosis factor α antagonists have different effects on host susceptibility to disseminated and oropharyngeal candidiasis in mice.Host responses to Candida albicans: Th17 cells and mucosal candidiasis.Th17 cytokines in mucosal immunity and inflammation.Effect of Delta-9-tetrahydrocannabinol on mouse resistance to systemic Candida albicans infection.Candida albicans heme oxygenase and its product CO contribute to pathogenesis of candidemia and alter systemic chemokine and cytokine expressionOral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections.The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.IL-12 and related cytokines: function and regulatory implications in Candida albicans infectionCD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model.CX3CR1 is dispensable for control of mucosal Candida albicans infections in mice and humans.Tailored immune responses: novel effector helper T cell subsets in protective immunity.Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection.Animal models of mucosal Candida infection.IL-17 signaling in host defense against Candida albicans.Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model.Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.Adaptive immune responses to Candida albicans infection.Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.Rethinking T cell immunity in oropharyngeal candidiasisAntibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.Ageing exacerbates damage of systemic and salivary neutrophils from patients presenting Candida-related denture stomatitis.A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17.Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.High Interleukin-12 Levels May Prevent an Increase in the Amount of Fungi in the Gastrointestinal Tract during the First Years of Diabetes Mellitus Type 1.Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.Rheumatoid arthritis patients exhibit impaired Candida albicans-specific Th17 responsesTh17 cells in immunity to Candida albicans.Recent advances in host defense mechanisms/therapies against oral infectious diseases and consequences for systemic disease.Pathogenicity mechanisms and host response during oral Candida albicans infections.A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis.Loss of immune control in HIV-infected patients: how does mucosal candidiasis occur?Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.The Role of IL-17 in Protection against Mucosal Candida Infections.Candida Immunity
P2860
Q26799351-F189AE47-4B4C-4378-8A88-FDA52F2D2D52Q27005798-15885442-4188-4A89-8F07-D2301AAEAE01Q30543923-C269938F-660D-4279-9DAE-815CBDEFECF0Q33611067-3B2F4C02-A30E-4EAC-ADD3-2BEC2A3FAC21Q33804673-161AB860-13CC-4E26-BA88-0EB05607FA01Q33927362-B89E43DA-D38A-4618-89D5-E4C51EDBD83FQ33941537-0FC518D3-2D0B-4BE6-926D-AC32E8FEAF80Q33943805-5F0105B8-2053-460D-B29E-07545BE05161Q33946093-5E1FF54F-8D5A-44F5-840B-D748A7497A7EQ34188778-62D714B6-00D9-4668-8EC8-48216DE89694Q34230506-7FEEACA0-DEF0-452C-9A85-9AE1E2E337C0Q34235746-AB275574-3465-40F7-8A03-829F358061F7Q34261517-06FBDBED-F2F2-4ACE-B16E-568F1CAE5E4BQ34627919-31E148F1-EBEC-4F3F-BBDF-705DD5F8684BQ35098244-89AD41F0-F1AC-4F6F-A7D3-E5A59390F9F2Q35105613-7827287C-35A8-4D04-BF83-B22151B6EB9FQ35208352-3FBEC19F-1262-4B45-91B2-8AA543EEC464Q35629652-D5C6CB09-6AD7-49F1-8E1D-B426CC4063FDQ35671394-173EED60-2484-47C4-B183-4168F5028130Q35949651-61572AC8-1DEE-41FC-AE4A-21E33CF8AF56Q36046570-2E1EC0F2-2165-438C-B3D6-27A5320711F9Q36147114-F23DD982-EAC4-494C-A788-25484F1F4E1DQ37106755-D22EC8AE-81F3-4FC0-B19A-9A2948EB299FQ37106783-BB76E0DB-10F8-4150-96DF-CEF2C134817BQ37111268-12CFE59D-767A-46F5-8792-1045C31921F0Q37159287-27DF1518-F722-4606-8A8F-8D26EA222A4CQ37249268-68F4DDB2-5A7D-41EB-983C-A8DCDC77E652Q37333439-7D4238EC-B8EA-43E2-89DE-D4B774275492Q37581295-7CC358B3-E835-4D03-9D7C-311BAF6E634CQ37643893-F9ADC1CB-CC34-494A-92F1-80C74658271CQ37690335-407224EF-5E09-48AC-965B-2869E126E2CDQ38011298-9D575E1B-38EA-4FA1-BED2-13B3A4887894Q38204891-ED435B3B-412F-44DD-9D78-6CD4578F43D9Q38209882-B8568501-F6E1-468F-A9C9-58CC3F9CB526Q38654282-9235E1DE-C17B-4160-A824-720A7554039DQ38786612-092E7EDD-45A7-4374-B656-1BFB4BE5EA9DQ39318147-D2AC87A4-AC75-40F8-9EA1-F093DF9927C4Q40183738-6425B7B5-AE39-46E5-AE72-27C809F80D4CQ49184561-31408421-6073-4A25-A8B2-E0CDDB7919A5Q59072636-46B13243-0061-479A-B5A4-7ECF5F93A3BB
P2860
Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Distinct roles for interleukin ...... sis defined by gene-targeting.
@en
Distinct roles for interleukin ...... sis defined by gene-targeting.
@nl
type
label
Distinct roles for interleukin ...... sis defined by gene-targeting.
@en
Distinct roles for interleukin ...... sis defined by gene-targeting.
@nl
prefLabel
Distinct roles for interleukin ...... sis defined by gene-targeting.
@en
Distinct roles for interleukin ...... sis defined by gene-targeting.
@nl
P2093
P2860
P1476
Distinct roles for interleukin ...... sis defined by gene-targeting.
@en
P2093
P2860
P304
P356
10.1111/J.1399-302X.2006.00288.X
P577
2006-08-01T00:00:00Z